Abstract:OBJECTIVE:To study the distribution of IL-6 receptors (CD(126) and CD(w130)) on lymphocytes in patients with lupus nephritis (LN). METHOD:The percentages of lymphocyte subsets were examined by direct two colour immunofluorescence on flow cytometry. RESULTS:(1) In active and inactive cases, the percentages of CD(+)(4) cells obviously decreased as compared with the normal controls (P < 0.01). Increased numbers of CD(+)(8) cells could be detected in LN patients (P < 0.05), especially in active cases (P < 0.01). Lymphocytes of active cases contained significantly greater percentage of CD(+)(23) cells than those of normal subjects (P < 0.05). On the contrary, the percentage of CD(+)(23) cells was statistically lower in the inactive cases than in normal subjects (P < 0.01). No significant difference in the percentages of CD(+)(126) and CD(+)(w130) cells was observed among the active, inactive and healthy groups (P > 0.05); (2) The proportion of CD(+)(4) CD(+)(126) and CD(+)(4) CD(+)(w130) cells in total lymphocytes was significantly lower in the active than in the inactive ones or normal subjects (P < 0.05; P < 0.01), whereas that of CD(+)(8) CD(+)(126) and CD(+)(8) CD(+)(w130) cells was not different among the active, inactive and normal subjects (P > 0.05). The proportion of CD(+)(23) CD(+)(126) cells and CD(+)(23) CD(+)(w130) cells augmented significantly in the active (P < 0.05), whereas it lessened in the inactive without statistical meaning as compared with the normal subjects (P > 0.05). (3) There was a positive correlation between the percentage of CD(+)(23) CD(+)(126) cells and that of CD(+)(23) CD(+)(w130) cells in total lymphocytes in the active group (r = 0.756, P < 0.05). However, no correlation between the percentage of CD(+)(23) CD(+)(126) cells and that of CD(+)(23) CD(+)(w130) cells in total lymphocytes was found in the inactive (r = 0.376, P > 0.05) or normal group (r = 0.256, P > 0.05); (4) The fraction of CD(+)(23) cells expressing CD(126) and CD(w130) was related to the SLE disease activity index (SLEDAI) and lymphopenia (P < 0.05, P < 0.005). But it was neither associated with the number of damaged organs and the degree of damage, not with that of ANA, anti-dsDNA antibody and complements (C(3) and C(4)) (P > 0.05). CONCLUSIONS:LN patients present not only B cell hyperactivity but also T cell abnormality. In active cases, there is abnormal distribution of IL-6 receptors on lymphocytes: reduced CD(126) and CD(w130) expression on CD(+)(4) cells and elevated CD(126) and CD(w130) expression on CD(+)(23) cells. Detecting the proportion of CD(+)(23) CD(+)(126) cells or CD(+)(23) CD(+)(w130) cells in total lymphocytes may serve as one of activity indexes for LN patients.

CD56brightCD16-to CD57+CD56dimCD16+NK Cell Ratio Discriminates Disease Activity and Renal Involvement in Patients with Systemic Lupus Erythematosus

Peripheral CD24hi CD27+ CD19+ B Cells Subset As a Potential Biomarker in Naïve Systemic Lupus Erythematosus.

Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.

Aberrant T Cell Subsets and Cytokines Expression Profile in Systemic Lupus Erythematosus.

Activation Status of CD56dim Natural Killer Cells is Associated with Disease Activity of Patients with Systemic Lupus Erythematosus

[Clinical Significance of CD4+CD25+ T Cells in Peripheral Blood of Patients in Systemic Lupus Erythematosus].

Abnormal Expression of Cd43 in Patients with Systemic Lupus Erythematosus and Its Clinical Significance

Neutrophil-to-C3 Ratio and Neutrophil-to-lymphocyte Ratio Were Associated with Disease Activity in Patients with Systemic Lupus Erythematosus

Decreased natural killer T-like cells correlated to disease activity in systemic lupus erythematosus

Differential Expression Of Natural Killer Activating And Inhibitory Receptors In Patients With Newly Diagnosed Systemic Lupus Erythematosus

Frequency and Significance of CD4+CD25+T Cell Subpopulations in the Peripheral Blood of Patients with Systemic Lupus Erythematosus

The Expression of Peripherial Blood Neutrophil CD64 in Systemic Lupus Erythematosus with Infection or Disease Activation

Natural Killer Cell Count in Systemic Lupus Erythematosus Patients: A Flow Cytometry-Based Study

The Expression pattern of NK cells in systemic lupus erythematosus patients with different disease activities

Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients

[Distribution of Interleukin-6 Receptors (CD(126) and CD(w130)) on Circulating Lymphocytes in Patients with Lupus Nephritis].

Double Negative B Cell is Associated with Renal Impairment in Systemic Lupus Erythematosus and Acts As a Marker for Nephritis Remission.

Significance of CD69/CD3 Ratio of Peripheral Blood Mononuclear Cells As a Marker for Evaluating the Disease Activity of Systemic Lupus Erythematosus

Identification and Characterization of CD8+CD27+CXCR3− T Cell Dysregulation and Progression‐Associated Biomarkers in Systemic Lupus Erythematosus

Correlation between levels of dendritic cell subsets in systemic lupus erythematosus patients and SLEDAI

A potential biomarker of disease activity in systemic lupus erythematosus, systemic immune-inflammation index